Establishing a Prognostic Model with Ferroptosis-related Long Non-coding RNAs in Bladder Cancer

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2023 Sep 13

PMID 37701097

Authors

Weisheng Li

Yang Xiong

Junlei Zhu

Xiaoxiao Jin

Jin Meng

Wenqiang He

Affiliations

Soon will be listed here.

Abstract

Background: Ferroptosis is a distinct form of cell death that has the potential to supersede the drug resistance that is commonly observed with current chemotherapeutic agents. As a result, ferroptosis presents a new and innovative therapeutic pathway for cancer treatment. The current understanding regarding the expression of genes associated with ferroptosis in bladder cancer (BLCA) and their prognostic implications remains unclear. Consequently, this study aimed to examine the potential prognostic value of ferroptosis-associated long non-coding RNAs (lncRNAs) in BLCA.

Methods: The Cancer Genome Atlas (TCGA) was accessed to download RNA sequencing data and clinicopathological features of BLCA while accessing the FerrDb database to download ferroptosis-associated genes. The study calculated risk scores for ferroptosis-associated lncRNAs, and subsequently divided patients with BLCA into two groups, namely high- and low-risk, on the basis of the median risk score. Moreover, Kaplan-Meier (K-M) curves, Cox regression analysis, and column plots were utilized for evaluating the risk score prognostic value. Subsequently, the involvement of ferroptosis-associated mRNA, N6-methyladenosine (m6A) mRNA status, and immune responses was investigated for BLCA prognosis.

Results: Thirty-six lncRNAs were identified to be differently expressed and linked to the prognosis of BLCA. The findings from the K-M curve analysis indicated a significant association between a high-risk lncRNA profile and poor BLCA prognosis. The area under curve (AUC) value of the receiver operating characteristic (ROC) curve was 0.810. The risk assessment model exhibited superior performance in predicting prognosis for BLCA compared to conventional clinicopathological features.

Conclusions: Thirty-six lncRNAs were found to be linked to ferroptosis for the prognosis of patients with BLCA, and these results may provide new insights for treating BLCA.

References

Li Q, Li K, Guo Q, Yang T . CircRNA circSTIL inhibits ferroptosis in colorectal cancer via miR-431/SLC7A11 axis. Environ Toxicol. 2023; 38(5):981-989. DOI: 10.1002/tox.23670. View

Liu J, Wang Y, Yin J, Yang Y, Geng R, Zhong Z . Pan-Cancer Analysis Revealed as a New Biomarker for Prognosis and Immunotherapy. J Oncol. 2022; 2022:3477148. PMC: 8769850. DOI: 10.1155/2022/3477148. View

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

Shi J, Jiang D, Yang S, Zhang X, Wang J, Liu Y . LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer. Front Oncol. 2020; 10:846. PMC: 7325998. DOI: 10.3389/fonc.2020.00846. View

Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J . Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020; 13(1):110. PMC: 7418434. DOI: 10.1186/s13045-020-00946-7. View

Lu J, Xia Q, Lu Y, Liu Z, Zhou P, Hu H . Efficacy of intravesical therapies on the prevention of recurrence and progression of non-muscle-invasive bladder cancer: A systematic review and network meta-analysis. Cancer Med. 2020; 9(21):7800-7809. PMC: 7643689. DOI: 10.1002/cam4.3513. View

Zhang Z, Xu Z, Yan Y . Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer. Front Med (Lausanne). 2022; 8:793515. PMC: 8791230. DOI: 10.3389/fmed.2021.793515. View

Hassannia B, Vandenabeele P, Vanden Berghe T . Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019; 35(6):830-849. DOI: 10.1016/j.ccell.2019.04.002. View

Jiang L, Kon N, Li T, Wang S, Su T, Hibshoosh H . Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015; 520(7545):57-62. PMC: 4455927. DOI: 10.1038/nature14344. View

10.

Guan Z, Chen J, Li X, Dong N . Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation. Biosci Rep. 2020; 40(8). PMC: 7953492. DOI: 10.1042/BSR20201807. View

11.

Gao N, Li Y, Li J, Gao Z, Yang Z, Li Y . Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers. Front Oncol. 2021; 10:598817. PMC: 7775490. DOI: 10.3389/fonc.2020.598817. View

12.

Song X, Long D . Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases. Front Neurosci. 2020; 14:267. PMC: 7186402. DOI: 10.3389/fnins.2020.00267. View

13.

Li Y, Yan J, Zhao Q, Zhang Y, Zhang Y . ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression. Front Pharmacol. 2022; 13:904314. PMC: 9537618. DOI: 10.3389/fphar.2022.904314. View

14.

Mou Y, Wang J, Wu J, He D, Zhang C, Duan C . Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019; 12(1):34. PMC: 6441206. DOI: 10.1186/s13045-019-0720-y. View

15.

Gil N, Ulitsky I . Regulation of gene expression by cis-acting long non-coding RNAs. Nat Rev Genet. 2019; 21(2):102-117. DOI: 10.1038/s41576-019-0184-5. View

16.

Newman A, Liu C, Green M, Gentles A, Feng W, Xu Y . Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015; 12(5):453-7. PMC: 4739640. DOI: 10.1038/nmeth.3337. View

17.

Qu L, He X, Tang Q, Fan X, Liu J, Lin A . Iron metabolism, ferroptosis, and lncRNA in cancer: knowns and unknowns. J Zhejiang Univ Sci B. 2022; 23(10):844-862. PMC: 9561407. DOI: 10.1631/jzus.B2200194. View

18.

Miess H, Dankworth B, Gouw A, Rosenfeldt M, Schmitz W, Jiang M . The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene. 2018; 37(40):5435-5450. PMC: 6173300. DOI: 10.1038/s41388-018-0315-z. View

19.

Cheng X, Wang Y, Li Y, Liu W . Quantification of ferroptosis pattern in bladder carcinoma and its significance on immunotherapy. Sci Rep. 2022; 12(1):9066. PMC: 9156752. DOI: 10.1038/s41598-022-12712-5. View

20.

Chen X, Kang R, Kroemer G, Tang D . Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021; 18(5):280-296. DOI: 10.1038/s41571-020-00462-0. View